ARS Pharmaceuticals, Inc. (SPRY)

5.62 -0.05 (-0.88%) USD  |  NASDAQ  |  Sep 04, 16:00
5.62 0.00 (0.00%) After-Hours: 18:51
More

ARS Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for SPRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2021. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
Date Value
December 31, 2022 --
December 31, 2021 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Passage Bio, Inc. --
Vertex Pharmaceuticals, Inc. Upgrade
Capricor Therapeutics, Inc. --
Kyntra Bio, Inc. Upgrade
Zentalis Pharmaceuticals, Inc. --